Best Cardiac Diabetic Product List in India- India has experienced a remarkable demand for Cardiac Diabetic medication in the past few years. The country has a vast population suffering from diabetes and Cardiovascular Disease. According to the International Diabetes Federation (IDF) 2024 for India. Around 10.5% of adults (20-79 years) in India are suffering from Diabetes. Whereas, 11% of adults are related to Cardiovascular Disease. Hence, this has created a substantial demand for effective and reliable cardiac diabetic medicines.
As both these conditions often coexist, patients require a specialized line of products that ensures holistic management and improved quality of life. Additionally, this growing demand has accelerated the expansion of the cardiac diabetic segment in the Indian pharmaceutical Landscape. Along with driving innovation, better formulations, and enhanced patient-centric solutions. Medfence Labs has emerged as a trusted manufacturer and supplier of high-quality cardiac diabetic products.
Medfence Labs presents a detailed insight into the Best Cardiac Diabetic Product List in India, offered by them, highlighting their trusted formulation and medical benefits. Associate with them for PCD and third-party manufacturing business opportunities.

Medfence Labs is among the most renowned names in the Pharmaceutical realm, known for its quality products and patient-centric approach. With more than 7 years of experience in this segment, they have established themselves among the leading leaders. The organization is involved in manufacturing and distributing a wide array of pharmaceutical formulations across various segments.
One of them is Cardiac Diabetic, which is designed to meet and treat various heart-related conditions and diabetes, addressing the interconnected nature of these diseases. Explore a wide range of Best Cardiac Diabetic Product List in India offered by Medfence Labs, along with their composition and type, mentioned as follows:
| Product Name | Composition | Type |
| AMLOFENS-AT | Amlodipine + Atenolol | Tablet |
| ATORFENS-10 | Atorvastatin 10 mg | Tablet |
| ATORFENS-20 | Atorvastatin 20 mg | Tablet |
| DAPAFENS-10 | Dapagliflozin 10 mg | Tablet |
| GLIMIFENS-GP2 | Glimepiride + Pioglitazone | Tablet |
| GLIMIFENS-M1 | Glimepiride + Metformin | Tablet |
| GLIMIFENS-M2 | Glimepiride + Metformin | Tablet |
| ISOFENS-40SR | Isosorbide Mononitrate 40 mg | Sustained-Release Tablet |
| LABIFENS | L-Acetyl Carnitine | Tablet |
| NORAFENS INJ | Noradrenaline / Norepinephrine | Injection |
| OLMEFENS-40 | Olmesartan Medoxomil 40 mg | Tablet |
| OLMEFENS-H | Olmesartan Medoxomil + Hydrochlorothiazide | Tablet |
| RAMIFENS-5 | Ramipril 5 mg | Tablet |
| ROSUFENS-20 | Rosuvastatin 20 mg | Tablet |
| ROSUFENS-GOLD | Rosuvastatin + Clopidogrel + Aspirin | Tablet (Combination) |
| TELMIFENS-40 TAB | Telmisartan 40 mg | Tablet |
| TELMIFENS-AM | Telmisartan + Amlodipine | Tablet |
| TELMIFENS-CL | Telmisartan + Chlorthalidone | Tablet |
| TELMIFENS-H TAB | Telmisartan + Hydrochlorothiazide | Tablet |
| TENLIFEN-20 | Teneligliptin 20 mg | Tablet |
| TENLIFENS-M ER 500 | Teneligliptin + Metformin (Extended Release) | Extended-Release Tablet |
| TORSEFEN -10 | Torsemide 10 mg | Tablet |
| TRIPTOFEN-10 | Trimetazidine 10 mg | Tablet |
| VILGAFEN-50 | Vildagliptin 50 mg | Tablet |
| VILGAFEN-M500 | Vildagliptin + Metformin | Tablet |
| VOGIFEN-0.2 DT | Voglibose 0.2 mg | Dispersible Tablet |
| VOGIFEN-M SR O.2 | Voglibose + Metformin (Sustained Release) | Sustained-Release Tablet |
In this lucrative and ever-blooming pharmaceutical industry, Medfence Labs emerges as a prominent name offering PCD Pharma Franchise for Cardiac Diabetic products. Backed by advanced manufacturing facilities that comply with WHO, ISO, and GMP certifications. Their robust infrastructure is equipped with modern technology, quality testing laboratories, and a skilled team of professionals dedicated to innovation and excellence.
Every product undergoes strict quality control measures to meet domestic and international quality standards. Our transparent business ethics, on-time delivery, and marketing support make us the most reliable partner for pharma professionals seeking sustainable growth in this specialized therapeutic segment.
We provide our partners with a territory-based monopoly right to eliminate the intra-brand competition. The company’s extensive range of Cardiac Diabetic products caters to the growing demand for managing cardiovascular diseases and diabetes.
Key Benefits of Partnering with us for PCD Pharma Franchise Business Opportunities:
Medfence Labs stands out as a trusted and progressive name in the Indian pharmaceutical industry, especially in the cardiac diabetic segment. The company is driven by a strong commitment to innovation, patient safety, and consistent product quality. Every formulation is developed using clinically tested ingredients and manufactured under strict WHO-GMP and ISO-certified standards, ensuring reliability and therapeutic efficacy.
What truly sets Medfence Labs apart is its focus on creating accessible and affordable healthcare solutions without compromising on quality. Their cardiac diabetic range is backed by advanced research, modern production technology, and continuous quality assurance, catering to both healthcare professionals and patients’ evolving needs.
In addition, the company offers robust business support to its franchise partners, including exclusive rights, timely deliveries, free marketing, and promotional support, making the partnership both profitable and dependable. Choosing Medfence Labs means choosing trust, transparency, and a vision for better health outcomes.
Medfence Labs continues to redefine excellence in cardiac diabetic care with its wide product portfolio and unwavering dedication to quality. For professionals seeking reliable business growth and patients seeking effective therapy. The company’s commitment to quality, safety, efficacy, and affordability makes it a preferred choice for healthcare professionals and PCD Pharma Franchise in PAN India. Medfence Labs positioned itself with trust, innovation, and care.
Q1. What makes Medfence Labs’ cardiac diabetic products different?
Medfence Labs’ products are GMP-certified, clinically tested, and scientifically formulated to provide dual benefits, regulating blood glucose and supporting heart health. The company focuses on quality, affordability, and innovation to help patients achieve better outcomes.
Q2. Does Medfence Labs provide marketing or promotional support to its franchise partners?
Yes. Medfence Labs offers comprehensive promotional support, including visual aids, sample kits, MR bags, and digital marketing material, to help franchise partners effectively promote products and grow their business in the cardiac diabetic segment.
Q3. Does Medfence Labs offer PCD Pharma Franchise opportunities in the cardiac diabetic segment?
Yes. Medfence Labs provides profitable and monopoly-based PCD Pharma Franchise opportunities across India. Franchise partners receive an exclusive product range, high profit margins, full promotional support, and much more.